WHO's premature linking of Gambia children deaths to Indian cough syrups adversely affected pharma industry's image: DGCI
Drugs Controller General of India (DCGI) Dr V G Somani said a statement issued by WHO in October in the wake of the deaths "was unfortunately amplified by the global media which led to a narrative being built internationally targeting the quality of Indian pharmaceutical products".
Dec 15, 2022, 22:25 PM IST
Government panel recommends emergency approval of Serum Institute’s Covovax for 7-11 year age group
"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources said.
Jun 25, 2022, 09:10 AM IST
'Proven record for safety': Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 years
"Covaxin has established a proven record for safety and efficacy in adults for the original variant and subsequent variants. We have documented excellent safety and immunogenicity data readouts in Children," Bharat Biotech said.
Dec 26, 2021, 06:16 AM IST
DGCI approves trial of mixed vaccination
The DGCI has given permission to conduct a study on the application of mixed doses of Covaxin and Covishield. This study and its clinical trials will be conducted by the Christian Medical College, Vellore.
Aug 11, 2021, 13:32 PM IST
Vaccine no. 4 is almost here, Cipla gets nod to import Moderna jab
Pharmaceutical company Cipla has now got Drugs Controller General of India’s (DCGI) nod to import Moderna's COVID-19 vaccine for restricted emergency use in India, say sources
Jun 29, 2021, 15:37 PM IST
Bharat Biotech's Covaxin gets DCGI nod to conduct clinical trials on children above 2 years
The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded permission to Covaxin manufacturer Bharat Biotech.
May 13, 2021, 11:52 AM IST
Breaking news: DGCI approves emergency use of Zydus Cadila's Virafin for moderate COVID-19 infection
Drugs Controller General of India, DGCI, on Friday (April 23) approved the emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate COVID-19 infection in adults.
Apr 23, 2021, 15:53 PM IST
Know all the major updates on the COVID-19 vaccine
Know the major updates on Corona vaccine so far, DGCI approves emergency use of two vaccines.
Jan 03, 2021, 18:18 PM IST
PM Modi's tweet on Corona vaccines approval, said proud opportunity for India
PM Modi congratulated the countrymen on the approval of the use of corona vaccine and also thanked all the scientists through a tweet.
Jan 03, 2021, 12:40 PM IST
'Double good news' on Corona vaccine, DCGI approved Covishield & Covaxin
DCGI has made a big announcement on the Corona vaccine. DCGI has given final approval for the emergency use of the Serum Institute's vaccine Covishield and Bharat Biotech's Covaxin.
Jan 03, 2021, 12:30 PM IST
Breaking News: Pfizer India sought permission from DGCI
Pfizer India wrote a letter to the DGCI seeking permission for the emergency use of the vaccine. Pfizer has been approved in Britain and Bahrain.
Dec 06, 2020, 09:10 AM IST
